摘要
目的:探究对急性心肌梗死合并心律失常患者临床采取胺碘酮结合β受体阻滞剂治疗对心功能的改善作用。方法:随机选取新密市第一人民医院2017年3月—2018年3月间收治的100例性心肌梗死合并心律失常患者,所有患者以治疗模式差异分为参照组(50例,胺碘酮治疗)和研究组(50例,胺碘酮+β受体阻滞剂治疗),对比分析两组患者治疗结束后心功能指标和最终治疗效果。结果:研究组患者的心功能指标明显优于参照组,且研究组患者的最终治疗有效率为96%(48/50)明显高于参照组82.00%(41/50),所有对比均差异明显(P<0.05)。结论:对急性心肌梗死合并心律失常患者临床采取胺碘酮结合β受体阻滞剂治疗,可有效改善患者心功能,降低不良反应发生率,有较高的治疗应用价值。
Objective:To explore the clinical effect of amiodarone combined withβ-blockers on cardiac function in patients with acute myocardial infarction and arrhythmia.Methods:100 patients with myocardial infarction and arrhythmia admitted in the hospital from March 2017 to March 2018 were randomly selected.All patients were divided into reference group(50 cases,amiodarone treatment)and study group(50 cases,amiodarone+β-blockers treatment)according to the difference in treatment mode.Cardiac function indexes and final treatment effect of two groups of patients after treatment were compared and analyzed.Results:The cardiac function indexes of the study group were significantly better than the reference group,and the final treatment effective rate of the study group was 96%(48/50),which was significantly higher than that of the reference group 82.00%(41/50),the differences were statistically significant(P<0.05).Conclusion:For patients with acute myocardial infarction complicated with arrhythmia,amiodarone combined withβ-blockers can effectively improve the heart function of patients,reduce the incidence of adverse reactions,and have high therapeutic value.
作者
孔国贤
李战峰
KONG Guo-xian;LI Zhan-feng(Department of Cardiovascular Medicine,First People's Hospital,Xinmi,Henan,452370,China)
出处
《黑龙江医学》
2021年第8期789-790,793,共3页
Heilongjiang Medical Journal